Trials / Completed
CompletedNCT02609295
Effects of α-linolenic Acid Supplementation on Hemostasis in Nondiabetic and Hypercholesterolemic Subjects
Effects of α-linolenic Acid Supplementation in the Form of Perilla Oil on Collagen-epinephrine Closure Time, Activated Partial Thromboplastin Time and Lp-PLA2 Activities in Nondiabetic and Hypercholesterolemic Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 86 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 40 Years – 68 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates whether ALA intake alters total cholesterol and homeostatic factors and the relationship between these alteration and lipoprotein associated phospholipase A2 (Lp-PLA2) activity.
Detailed description
An 8-week, randomized, double-blind, placebo-controlled study was conducted with 86 nondiabetic and borderline-to-moderate hypercholesterolemic (200mg/dL ≤ serum cholesterol ≤ 300mg/dL) subjects, not taking any medications and supplements to affect lipid metabolism, platelet function and inflammation, divided into two groups: an α-linolenic acid (ALA) group \[1.2 g (two capsules) of perilla oil daily; 497 mg ALA\] and a placebo group (1.2 g of medium-chain triglyceride oil daily).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | 1.2 g (two capsules) of medium-chain triglyceride (MCT) oil |
| DIETARY_SUPPLEMENT | ALA group | 1.2 g (two capsules) of perilla oil |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2015-11-20
- Last updated
- 2016-01-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02609295. Inclusion in this directory is not an endorsement.